Vancomycin Activates σB in Vancomycin-Resistant Staphylococcus aureus Resulting in the Enhancement of Cytotoxicity
2011

Vancomycin Activates σB in Vancomycin-Resistant Staphylococcus aureus Resulting in the Enhancement of Cytotoxicity

publication Evidence: moderate

Author Information

Author(s): Chen Hong-Yi, Chen Chien-Cheng, Fang Chun-Sheng, Hsieh Yi-Ting, Lin Mei-Hui, Shu Jwu-Ching

Primary Institution: Chang Gung University

Hypothesis

We hypothesized that treatment with antibiotics may act as an environmental stressor that induces σB activity in antibiotic-resistant strains.

Conclusion

Vancomycin treatment activates σB in vancomycin-resistant S. aureus, leading to increased expression of virulence factors and enhanced cytotoxicity.

Supporting Evidence

  • Vancomycin treatment significantly increased the expression of σB and virulence genes in VRSA strains.
  • Sub-minimum inhibitory concentrations of antibiotics can act as environmental stressors.
  • Activation of σB was associated with increased cytotoxicity in human bronchial epithelial cells.

Takeaway

When bacteria that resist antibiotics are treated with vancomycin, it can actually make them more harmful by activating a stress response that increases their ability to cause disease.

Methodology

Real-time quantitative reverse transcription PCR and cytotoxicity assays were used to evaluate gene transcription levels and cell damage following antibiotic treatment.

Limitations

The study primarily focused on a single strain of vancomycin-resistant S. aureus, which may limit the generalizability of the findings.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0024472

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication